semaglutide vs tirzepatide efficacy comparison as Compared with for the Treatment of Obesity Semaglutide vs Tirzepatide: Which GLP-1

Now, FDA enforcement is going after pharmacies that make copies of drugs which are already on the market, unless there is a real medical reason

Add-on to metformin SURPASS-2 (NCT03987919) was a 40-week open-label trial (double-blind with respect to MOUNJARO dose assignment) that randomized 1879 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin alone to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or MOUNJARO 15 mg once weekly or subcutaneous semaglutide 1 mg once weekly

For example, if you usually inject on Monday, injecting on Tuesday or Sunday is safe

But how those 50 mg are distributed across the liquid volume changes the concentration entirely

That doesnt mean the medicine isnt working